These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5822012)

  • 1. [Clinical pharmacology and therapeutic applications of phenyl 3-dibutylamino-ethylamino 5 oxadiazole (LA 1221)].
    Sterne J
    Therapie; 1969; 24(4):745-55. PubMed ID: 5822012
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacological effect of phenyl-3-dibutylaminoethylamino-5 oxadiazole 1,2,4 (LA 1221), particularly on the peripheral vessels].
    Sterne J; Pelé MF; Hirsch C
    Therapie; 1969; 24(4):735-44. PubMed ID: 5822011
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical and experimental observations on a group of coronary disease patients treated with an oxadiazole derivative (phenyl-3-diethylaminoethyl-4-imino-5-oxadiazole-1,2,4 hydrochloride)].
    Strobbia R; Manzoni A; Dal Zotto U
    Minerva Med; 1970 Aug; 61(67):3507-15. PubMed ID: 5453990
    [No Abstract]   [Full Text] [Related]  

  • 4. [Separation and pharmacological study of 2 anantiomers of proxazole].
    De Feo G; Giannangeli M; Piccinelli D; Sale P
    Farmaco Sci; 1971 Apr; 26(4):370-6. PubMed ID: 5559995
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical results of the use of carbonyl-3-pyridine citrate (euclidin) during arterial disease].
    Berthier G; Berthier JP
    Sem Ther; 1965 May; 41(5):311-3. PubMed ID: 5878952
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of the aging man].
    Weiss O
    Med Welt; 1967 Jul; 26():1587-90. PubMed ID: 5616190
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of peripheral and cerebral circulation disorders. Experiences with bencyclan-hydrogenfumarate (Fludilat)].
    Frercks J
    Munch Med Wochenschr; 1971 Oct; 113(40):1293-8. PubMed ID: 5171108
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical evaluation of molsidomin in ischemic cardiopathy].
    Di Giacomo G; Nicolella U; Puligheddu M; Tripodi A; D'Ascoli C; Di Virgilio D
    Clin Ter; 1984 Oct; 111(2):141-6. PubMed ID: 6239736
    [No Abstract]   [Full Text] [Related]  

  • 9. 2-[3-(4-chloro/ethyl phenyl)propan-3-one]-5-(substituted phenyl)-1,3,4-oxadiazoles: synthesis and biological evaluation.
    Husain A; Sarafroz M; Ahuja P
    Acta Pol Pharm; 2008; 65(5):527-34. PubMed ID: 19051598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Imolamine in acute coronary insufficiency. Some considerations in the light of 30 treated cases].
    Caporicci D
    Clin Ter; 1977 Mar; 80(6):553-85. PubMed ID: 862356
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical evaluation of irrigor as a drug improving the coronary blood flow].
    Bolińska H; Kaluzna J
    Wiad Lek; 1970 Sep; 23(17):1491-3. PubMed ID: 5472083
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic results in peripheral and cerebrovascular blood circulation disorders following the administration of Dusodril].
    Kaufmann J; Förster W
    Z Allgemeinmed; 1970 May; 46(13):688-9. PubMed ID: 5522940
    [No Abstract]   [Full Text] [Related]  

  • 13. [Objective evaluation of the treatment of cerebral blood flow disorders with Spasmocyclone].
    Algan O; Kienle H
    Med Welt; 1969 Mar; 9():471-6. PubMed ID: 5771352
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacologic studies on the new antitussive agent, 3-(2,2-diphenylethyl)-5-(2-piperidinoethyl)-1,2,4-oxadiazole].
    Tardos L; Erdély I
    Arzneimittelforschung; 1966 May; 16(5):617-21. PubMed ID: 6014427
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experience with Irrigor, a new coronary effective substance].
    Christmann W
    Med Welt; 1968 Nov; 46():2559-60. PubMed ID: 5731381
    [No Abstract]   [Full Text] [Related]  

  • 16. [Influence of propaxoline on microcirculation. I. Propaxoline in the treatment of coronary insufficiency].
    Nigro G; Comi LI; Limongelli F; Giugliano MA
    Minerva Cardioangiol; 1976 Jan; 24(1):34-7. PubMed ID: 768805
    [No Abstract]   [Full Text] [Related]  

  • 17. Drugs in cerebral and peripheral arterial disease.
    Lowe GD
    BMJ; 1990 Feb; 300(6723):524-8. PubMed ID: 2107935
    [No Abstract]   [Full Text] [Related]  

  • 18. [Molsidomin in coronary disease. Clinico-pharmacokinetic correlation study on the effect of oral and sublingual therapy].
    Strasser R; Klepzig H; Ostrowski J; Resag K
    MMW Munch Med Wochenschr; 1983 Feb; 125(8):156-8. PubMed ID: 6405248
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment with sidnonimine derivatives of chronic ischemic heart disease patients].
    Kuz'ko NV
    Vrach Delo; 1984 Jul; (7):79-81. PubMed ID: 6548063
    [No Abstract]   [Full Text] [Related]  

  • 20. [Value of a long-term vasodilatator therapeutic agent in chronic arteritis obliterans at the pre- or post-operative state].
    Lewintre M
    Mars Med; 1971; 108(7):557-63. PubMed ID: 5119500
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.